Group One Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.6M Buy
+219,540
New +$34.7M 0.05% 309
2026
Q2
– Sell
-90,331
Closed -$11.5M – 8631
2026
Q1
$11.5M Buy
+90,331
New +$11.3M 0.02% 750
2025
Q4
– Sell
-24,191
Closed -$2.42M – 9305
2025
Q3
$2.42M Buy
+24,191
New +$2.18M ﹤0.01% 2113
2025
Q2
– Sell
-5,605
Closed -$455K – 8757
2025
Q1
$455K Buy
+5,605
New +$501K ﹤0.01% 3193

Other funds holding XBI

Group One Trading's XBI Position: Q3 2026 in Review

Group One Trading opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 219,540 shares worth $34.6M. The stake represents 0.05% of the portfolio and ranks #309 among its holdings. This is a return to the name: Group One Trading previously reported a position in XBI as recently as Q1 2026.

Group One Trading first reported a position in XBI in Q1 2025 and has held it in 4 quarters since. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Group One Trading held 219,540 shares of State Street SPDR S&P Biotech ETF worth $34.6M as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Group One Trading position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.05% of Group One Trading's portfolio in Q3 2026, its #309 holding.
  • Group One Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 4 quarters since.
  • 604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.